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Abstract 
Introduction. cardiac involvement in systemic sclerosis (SSc) and represents a major cause 
of morbidity and mortality and constitue an evolutionary turning turnpoint in this disease. 
Purpose of the work was to describe echocardiographic data in asymptomatic patients with 
SSc and compare them to results obtained in a control population in order to unmask 
subclinical cardiac involvement during systemic sclerosis. 
Material and methods. Prospective study conducted between 2012 and 2017. Including 2 
groups: Group A included 25 asymptomatic scleroderma patients without other 
comorbidities, Group B consisted of 25 control and healthy subjects. The two groups were 
explored by echocardiography coupled to tissue Doppler and 2Dstrain. 
Results. The mean age of our patients was 45 ± 7 years. The sex ratio was 0.8 The control 
population was on the characteristic epidemiological similar to the group of patients. The 
anatomical data of the left ventricle, the ejection fraction normal and comparable between the 
two groups, the TEI index was significantly higher in the A group (0.8 ± 0.04 vs 0.28 ± 0.07, 
p < 0.01). Tissue Doppler velocity S peak measurement was reduced in group A compared to 
group B (5.6 ± 0.5 vs ± 9.30 ± 0.5, p < 0.01), global longitudinal strain was also altered in 
scleroderma patients ( -11 ± 0.4 vs -18. ± 0.3 < 0.01). There was no significant difference in 
E / A ratio, however early LV diastolic dysfunction was revealed by a higher E / Ea and E / 
VP ratio in group A compared to group B with respectively (13 ± 1.8 vs 6 ± 1.6 , p < 0.01) 
and (2.2 ± 0.6 vs. 1.5± 0.6 p < 0.01), a longer Ap-Am duration (≥ 20 ms) and a higher 
volume of the left atrium was noted in groupe A. The mean value of the pulmonary pressions 
was 37.9 ± 9 mmHg in patients with scleroderma vs. 25 ± 3 mmHg for the control group (p < 
0.01).There was no right ventricular dysfunction  
Conclusions. Cardiac involvement during systemic sclerosis precede clinical expression, 
echocardiography coupled with tissue doppler and 2D strain are useful to detect these 
abnormalities at a subclinical stage of the disease. 
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Introduction  
The occurrence of cardiac involvement in systemic sclerosis (SSc) is an evolutionary turning 
point in this disease and represents a major cause of morbidity and mortality from this 
systemic pathology. It appears that a histological lesions of the heart in SSc would be much 
more frequent and earlier than clinical symptoms 
Purpose of study was to unmasking any signs of left ventricular dysfunction in a 
subclinical stage of the disease scleroderma by appreciating echocardiography systolic and 
diastolic function in asymptomatic patients with SSSc and comparing the echocardiographic 
findings in these patients to those with the results obtained in a control population. 
 
Material and methods  
A prospective descriptive and comparative study was conducted in the adult cardiology 
department of the Rabta Hospital over a period of 5 years from 2012 to 2017. the relatively 
long inclusion period is due to the difficulty of recruiting patients because of the rarity of this 
systemic disease, to which is added the imperative that these patients must be functionally 
asymptomatic and free from any other comorbidity. 
 
Inclusion criteria: 
– Group A: 25 asymptomatic scleroderma patients without signs of heart failure who 
did not have other comorbidities that could interfere with left ventricule( LV) 
function. 
– Group B: 25 control and healthy subjects. 
 
Exclusion criteria: 
– Patients with high blood pressure, diabetes, valvular heart disease, ischemic heart 
disease. 
– Patients were explored by conventional echocardiography coupled to tissue Doppler 
and 2D strain. Several parameters have been collected and compared between two 
group in particular :left ventricular anatomic measurements (diameter ,septum 
thikness), left ventricular function (ejection fraction (EF), Tei index, S wave at Tissue 
Doppler, as well as global longitudinal strain) and diastolic function (mitral profile, E 
/ E wave ratio, VP, duration of the mitral wave minus the pulmonary wave, left atrium 
volume). 
 Statistical studies: We calculated simple frequencies and relative frequencies 
(percentages) for qualitative variables, means, medians and standard deviations (standard 
deviations) for quantitative variables.we used the chi-square test and the student test 
respectively for the comparison of two percentages and two averages , in all the statistical 
tests, the significance level was fixed at 0.05 
 
Results  
Epidemiological data of the two groups were reported in Table 1.  
 Both groups A and B were free from comorbidities (arterial hypertension, diabetes, 
ischemic heart disease).The diagnosis of SSc in our patients went back several years with an 
average of 6.5 years. All our patients were treated with corticosteroids; 55% of patients 
received calcium channel blockers due to Raynaud's syndrome. 
Anatomical features and LV systolic function for both groups were reported in Table 
2. 
LV diameter measurements and septum thickness were normal and comparable 
between the two groups. The Tei index in the group of scleroderma patients was 0.6 ± 0.08 
significantly higher than in the control group which was 0.28 ± 0.07 (p < 0.01). This therefore 
suggests the existence of an attributable left ventricular dysfunction during SSc that will have 
to be apprehended by other ultrasound methods. 
The LV ejection fraction was also comparable between the 2 groups. While the peak 
of systolic velocities S at the mitral annulus measured by the tissue Doppler mode (DTI) and 
the global longitudinal strain was definitely lowered in the group A compared to the group B 
attesting latent left ventricular systolic dysfunction in our scleroderma patients in subclinical 
stage. 
The study of the diastolic function of the left ventricle was reported in Table 3, the 
analysis of the parameters of the diastolic function by the pulsed Doppler mode, shows no 
significant differences between the two groups with respect to velocity peaks. protodiastolic 
E, end-diastolic A, E / A ratio. a normal or pseudo normal filling pattern was found in 82% of 
patients in group A and in 93% of group B. a significant difference between the two Groups 
was found concerning combined indices (E / VP, am-ap duration, E / Ea ratio, and left atrial 
volume). 
The elevation of pulmonary arterial pressures is one of the echocardiographic 
abnormalities found in our scleroderma patients,. The mean value pulmonary pressures was 
37 ± 9 mmHg for group A vs. 25 ± 3 mmHg for group B (p < 0.01). However, this relative 
pulmonary hypertension was not important, explaining the absence of functional impairment 
especially in our scleroderma patients. Moreover, there was no dysfunction of the right 
ventricle in both groups. 
 
Discussion 
Systemic scleroderma (SSc) is a generalized disease of interstitial and vascular connective 
tissue associated with abnormalities of the immune system (autoimmune disease) leading to 
fibrosis. The disease usually begins between 40 and 60 years of age [1]. the average age of 
our patients was 45 ± 7 years old..Women are more frequently affected than men (sex ratio 
8/10) [1]; this predominance was found in our study. Cardiac involvement in SSc is multiple 
and not very specific [2]. three tunics are interested but myocardial involvement is 
preponderant. It seems to be due to the combination of several mechanisms: myocardial 
ischemia in relation to coronary vasospasm, myocardial fibrosis, obliteration of the coronary 
microcirculation or an alteration of the capillary bed, all contributing to myocardial 
dysfunction [3]. 
 Cardiac involvement is most often asymptomatic, which is why its prevalence is 
underestimated: 8 to 28% depending on the studies [4], autopsy studies have reported 
myocardial involvement in 50 to 89% of subjects with SSc [5]. Indeed Angelo [5], in his 
autopsy series including 58 patients showed myocardial fibrosis in 81% of patients, while 
only 16% had cardiac manifestations during their lifetime. Histological and 
echocardiographic cardiac involvement precedes clinical expression, hence the interest of 
performing echocardiography in subjects with scleroderma to detect abnormalities of systolic 
and diastolic function that may appear several years before causing clinical signs [6]. Several 
studies [7, 8] have not noted a change in the anatomical features of LV during scleroderma. 
In our series, the values of anatomical parameters of LV were normal and comparable 
between the two groups. 
 Myocardial involvement in SSc affected often diastolic than systolic function, 
indeed several studies demonstrated that scleroderma patients had a normal EF, the mean EF 
was 69.5% in the Candella study[9] , 66.9% in the Meunes study [6] and 67.4% in the Plazak 
serie [10]. In our series, the ejection fraction in patients with scleroderma was normal and 
comparable to the control group with an average EF was 64 %.  
 Tissue Doppler by studying systolic velocities S at the mitral annulus is more 
reliable than EF for the detection of early LV systolic dysfunction [11]. It therefore appears 
much more sensitive than conventional ultrasound [12]. This notion has been reported in 
several studies that have shown that despite a normal found ejection fraction, there is a 
decrease in LV contractility in scleroderma patients detected by the study of tissue Doppler 
velocities thus attesting to the existence of an early systolic dysfunction underestimated by 
echocardiography. In our series, although LV EF was normal in patients with SSc, early 
systolic dysfunction was detected by à low value of the peak velocity of S measurement at the 
tissue Doppler. 
 Intersting studies on the contribution of D2 strain, in scleroderma patients are very 
rare. However, some authors have shown by an analysis of radial or longitudinal myocardial 
function its performance in the detection of systolic and early dysfunction of LV.This method 
was used by Coucelo [13], who studied the segments reflecting displacement of longitudinal 
fibers in scleroderma patients. He found a correlation between the deterioration of systolic 
and diastolic function in the studied segments and the degree of fibrosis, and Edoardo Rosato 
[14] similarly noted in his study of 76 scleroderma patients abnormalities in Longitudinal 
fibers 23% vs in function of radial fibers.8% In our series, GLS was altered in our 
scleroderma patients.  
 Myocardial involvement is much more often a diastolic lesion than a systolic one. It 
constitutes the essential manifestation of the primary cardiomyopathy of the SSc [4]. The 
transmural profile usually described in the scleroderma patients is type anomaly of relaxation. 
A mitral profile type I was found in 42% of the sclerodermic patients in the study. of 
Valentini [8]. A restrictive profile has also been reported in the literature but its frequency 
was lower; Fernandes [15] in a study with endomyocardial biopsies in asymptomatic patients 
without evidence of heart failure and excluding patients with hypertension, LV hypertrophy , 
LV systolic dysfunction found abnormality in the disposition of the patient collagen in 94%, 
indicating the almost constant myocardial involvement due to this fibrosis. Candella [9] 
supports this view, noting in his study that diastolic dysfunction found in scleroderma 
patients persisted after adjustment for blood pressure, heart rate, age, valvulopathy, 
pericardial effusion [16] confirming primary myocardial involvement in SSc 
 In our study, the 25 patients were completely asymptomatic without any clinical 
signs of heart failure and were free from any comorbidity that could interfere with the 
function of LV, we did not notice anomalies in the mitral profile.It can be concluded that 
diastolic dysfunction is certainly common, but may simply be due to associated comorbidities 
and not to primary myocardial involvement. and that diastolic alteration specifically related 
to scleroderma can only be discussed once other possible causes of diastolic dysfunction have 
been ruled out. 
 All studies highlight the limitations of evaluating diastolic function on transmitral 
flow alone, hence the contribution of tissue pulsed Doppler as a non-invasive method in the 
study of diastolic function at a subclinical stage. Indeed, by the Ea peak measurement on the 
septal side of the mitral annulus to the tissue Doppler, Ilknur Can [17] noted in patients with 
scleroderma a decrease in Ea compared to a control group , thus signaling early diastolic 
dysfunction. In our series, the tissue Doppler attest a a decrease in the value of Ea in 
scleroderma patients comparing to To the control group and confirm eventual diastolic 
dysfunction. Another indice to evaluate lv pressure was the E/Ea ratio in fact Ilknur [17] 
calculated this ratio in a group of scléroderma patients and a healthy group, this ratio was 
higher in the group of patients attesting a rise in LV filling pressure our results are similar to 
those reported in our series 
 The study of the duration Ap-Am, E / vp, the volume of the left atrium have not 
been the subject of several studies in the various series published in the literature , most 
studies were based on mitral flow analysis, velocity peak Ea measurement at the mitral 
annulus to tissue Doppler, and E / Ea ratio calculation. the values of these parameters were 
altered in our serie attesting a rise in filling pressure. 
 The exact prevalence of pulmonary artery hypertension (PAH ) during SSc is 
debated is in the range of 8 to 12% [18] ,According to the new classification proposed at the 
Third World Congress, pulmonary hypertension during the SSc can be either a PAH 
associated with systemic sclerosis or pulmonary arterial hypertension secondary to 
pulmonary fibrosis [19]. PAH was observed in our patients and it was not important, which 
also explains the lack of functional impairment especially in our scleroderma patients. 
 Although diastolic dysfunction of the left ventricle, and to a lesser extent systolic 
dysfunction, was well studied in scleroderma patients , the study o right ventricular function 
has not been studied extensively [20]. 
 
Limitations of our work 
The small size of our population is the main limitation of our work, and other single or multi-
center studies, including a larger number, will improve the validity of our results.  
 We have not also developed the contribution of this echocardiographic study in the 
decision of to prescribe or not a treatment in a totally asymptomatic scleroderma patients. 
 
Conclusion 
Our patients with sclérodermie were completely asymptomatic and without any clinical signs 
of heart failure, but the comparative study with a healthy population has identified by 
echocardiography coupled with tissue Doppler and 2D strain the presence of a latent 
subclinical cardiac involvement in SSc.The diagnosis of its anomalies allow appropriate 
thérapeutique approach (the vasodilatory drugs ) to early vasospastic and reversible 
abnormalities of the early myocardial disease observed in scleroderma.  
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 Group   A  Group B p 
Age  45 ±7  43  ±7 NS 
Sex 
ratio(female) 
0.8  0.8 ns 
BMI 22 ±1 24±4 ns 
diabete    5.6 ± 0.8    5.3 ±0.6 ns 
Systolic 
BP(mmhg) 
121± 1   117±2 ns 
Diastolic BP( 
mmhg ) 
78±5  72±5 Ns  
 
 
 
Table 1:epidemiological characteristics of study population. 
 
 
 
 
 
 
 
 
 
  Group A        
(25 patients) 
Group B(25 
témoins) 
p 
LVEDD (cm) 47± 0.5 45±0.5 0.1 
SIV (cm) 0.9 ± 0.1 0.8±0.1 0.2 
PP (cm)   0.9 ± 0.15 0.8±0.1 0.6 
EF  %)        63+-3       64±_1 0.45 
Tei index    0.6± 0.08     0.28±0.07 <0.01 
Peak  S velocity (cm/s) 5.6± 0.5 9.3±0.5 <0.01 
Global longitunal stain 
GLS (%)   
-11±0.4      -18±0.3       <0.01 
 
 
Table 2  :  anatomical features and LV systolic function in both groups of population 
 
 
 
 
 
 
 
         
 Figure1 :comparison TEI index                Figure2 : comparison Peak S velocity  
Betwen    two  groups                                   betwen two  groups                               
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Figure 3 :  comparison of GLS betwen  two groups   
GLS :global longitudinal strain                      
 
 
 
 
 
 Group  A Group B  P 
Peak E velocity  (cm/s) 89 ± 14 87± 16 0.6 
Peak A velocity (cm/s) 65 ± 12 64  ± 16 
 
0.4 
 E/A ratio  1.46± 0.3  1.32 ± 0.4 
 
0.3 
 E/Vp  ratio  2.3± 0.6 1.3± 0.6 <0.01 
Am-Ap duration   0 > 20ms <0.01 
Peak  velocity  at mitral 
annulus   Ea (cm/s) TD  
7.0 ± 1.2 11. ± 1.4 <0.01 
 E/Ea  ratio     12.71 ± 1.8 7.9 ±1.4 <0.01 
  Volume of left  atrium ml/m2         37.±9       25±  3 <0.01 
  
Table  3  : Features of diastolic LV function 
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Figure 4 : comparison of E/vp  betwen         Figure 5 : comparison of Ea   betwen 
Two  groups                                                             two groups   
 
 
 
 
                     
 
 
 Figure 6 :  comparison of E/Ea betwen            Figure 7: comparison of volume of left                 
 two groups                                                      betwen left atrium betwen 2groups 
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